MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols

神经影像学 医学 磁共振成像 痴呆 临床试验 疾病 神经科学 认知 生物标志物 重症监护医学 物理医学与康复 病理 放射科 心理学 精神科 生物化学 化学
作者
Hanzhang Lu,Amir H. Kashani,Konstantinos Arfanakis,Arvind Caprihan,Charles DeCarli,Brian T. Gold,Yang Li,Pauline Maillard,Claudia L. Satizábal,Lara Stables,Danny J.J. Wang,Roderick A. Corriveau,Herpreet Singh,Eric E. Smith,Bruce Fischl,André van der Kouwe,Kristin Schwab,Karl G. Helmer,Steven M. Greenberg
出处
期刊:Alzheimers & Dementia [Wiley]
卷期号:17 (4): 716-725 被引量:60
标识
DOI:10.1002/alz.12216
摘要

Abstract The MarkVCID consortium was formed under cooperative agreements with the National Institute of Neurologic Diseases and Stroke (NINDS) and National Institute on Aging (NIA) in 2016 with the goals of developing and validating biomarkers for the cerebral small vessel diseases associated with the vascular contributions to cognitive impairment and dementia (VCID). Rigorously validated biomarkers have consistently been identified as crucial for multicenter studies to identify effective strategies to prevent and treat VCID, specifically to detect increased VCID risk, diagnose the presence of small vessel disease and its subtypes, assess prognosis for disease progression or response to treatment, demonstrate target engagement or mechanism of action for candidate interventions, and monitor disease progression during treatment. The seven project sites and central coordinating center comprising MarkVCID, working with NINDS and NIA, identified a panel of 11 candidate fluid‐ and neuroimaging‐based biomarker kits and established harmonized multicenter study protocols (see companion paper “MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols” for full details). Here we describe the MarkVCID neuroimaging protocols with specific focus on validating their application to future multicenter trials. MarkVCID procedures for participant enrollment; clinical and cognitive evaluation; and collection, handling, and instrumental validation of fluid samples are described in detail in a companion paper. Magnetic resonance imaging (MRI) has long served as the neuroimaging modality of choice for cerebral small vessel disease and VCID because of its sensitivity to a wide range of brain properties, including small structural lesions, connectivity, and cerebrovascular physiology. Despite MRI's widespread use in the VCID field, there have been relatively scant data validating the repeatability and reproducibility of MRI‐based biomarkers across raters, scanner types, and time intervals (collectively defined as instrumental validity). The MRI protocols described here address the core MRI sequences for assessing cerebral small vessel disease in future research studies, specific sequence parameters for use across various research scanner types, and rigorous procedures for determining instrumental validity. Another candidate neuroimaging modality considered by MarkVCID is optical coherence tomography angiography (OCTA), a non‐invasive technique for directly visualizing retinal capillaries as a marker of the cerebral capillaries. OCTA has theoretical promise as a unique opportunity to visualize small vessels derived from the cerebral circulation, but at a considerably earlier stage of development than MRI. The additional OCTA protocols described here address procedures for determining OCTA instrumental validity, evaluating sources of variability such as pupil dilation, and handling data to maintain participant privacy. MRI protocol and instrumental validation The core sequences selected for the MarkVCID MRI protocol are three‐dimensional T1‐weighted multi‐echo magnetization‐prepared rapid‐acquisition‐of‐gradient‐echo (ME‐MPRAGE), three‐dimensional T2‐weighted fast spin echo fluid‐attenuated‐inversion‐recovery (FLAIR), two‐dimensional diffusion‐weighted spin‐echo echo‐planar imaging (DWI), three‐dimensional T2*‐weighted multi‐echo gradient echo (3D‐GRE), three‐dimensional T 2 ‐weighted fast spin‐echo imaging (T2w), and two‐dimensional T2*‐weighted gradient echo echo‐planar blood‐oxygenation‐level‐dependent imaging with brief periods of CO 2 inhalation (BOLD‐CVR). Harmonized parameters for each of these core sequences were developed for four 3 Tesla MRI scanner models in widespread use at academic medical centers. MarkVCID project sites are trained and certified for their instantiation of the consortium MRI protocols. Sites are required to perform image quality checks every 2 months using the Alzheimer's Disease Neuroimaging Initiative phantom. Instrumental validation for MarkVCID MRI‐based biomarkers is operationally defined as inter‐rater reliability, test‐retest repeatability, and inter‐scanner reproducibility. Assessments of these instrumental properties are performed on individuals representing a range of cerebral small vessel disease from mild to severe. Inter‐rater reliability is determined by distribution of an independent dataset of MRI scans to each analysis site. Test‐retest repeatability is determined by repeat MRI scans performed on individual participants on a single MRI scanner after a short (1‐ to 14‐day) interval. Inter‐scanner reproducibility is determined by repeat MRI scans performed on individuals performed across four MRI scanner models. OCTA protocol and instrumental validation The MarkVCID OCTA protocol uses a commercially available, Food and Drug Administration‐approved OCTA apparatus. Imaging is performed on one dilated and one undilated eye to assess the need for dilation. Scans are performed in quadruplicate. MarkVCID project sites participating in OCTA validation are trained and certified by this biomarker's lead investigator. Inter‐rater reliability for OCTA is assessed by distribution of OCTA datasets to each analysis site. Test‐retest repeatability is assessed by repeat OCTA imaging on individuals on the same day as their baseline OCTA and a different‐day repeat session after a short (1‐ to 14‐day) interval. Methods were developed to allow the OCTA data to be de‐identified by the sites before transmission to the central data management system. The MarkVCID neuroimaging protocols, like the other MarkVCID procedures, are designed to allow translation to multicenter trials and as a template for outside groups to generate directly comparable neuroimaging data. The MarkVCID neuroimaging protocols are available to the biomedical community and intended to be shared. In addition to the instrumental validation procedures described here, each of the neuroimaging MarkVCID kits will undergo biological validation to determine its ability to measure important aspects of VCID such as cognitive function. The analytic methods for the neuroimaging‐based kits and the results of these validation studies will be published separately. The results will ultimately determine the neuroimaging kits’ potential usefulness for multicenter interventional trials in small vessel disease–related VCID.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dh完成签到,获得积分10
2秒前
岩墩墩完成签到,获得积分10
3秒前
克姑美完成签到 ,获得积分10
6秒前
pangao完成签到,获得积分10
6秒前
ysssbq完成签到,获得积分10
8秒前
9秒前
上好佳完成签到 ,获得积分10
9秒前
大模型应助Yeong采纳,获得10
10秒前
量子星尘发布了新的文献求助30
10秒前
11秒前
123完成签到,获得积分10
11秒前
谢陈完成签到 ,获得积分10
12秒前
lilili完成签到,获得积分10
13秒前
14秒前
xiaoying发布了新的文献求助10
14秒前
SciGPT应助Eric_Liuzy采纳,获得10
15秒前
liu完成签到 ,获得积分10
15秒前
qixiaoqi发布了新的文献求助10
16秒前
17秒前
A溶大美噶发布了新的文献求助10
17秒前
18秒前
18秒前
19秒前
20秒前
21秒前
kevin发布了新的文献求助10
21秒前
满意的初南完成签到 ,获得积分10
22秒前
橙橙橙发布了新的文献求助10
22秒前
万能图书馆应助EVEN采纳,获得10
22秒前
22秒前
Yeong发布了新的文献求助10
23秒前
范先生发布了新的文献求助10
24秒前
disciple完成签到,获得积分10
25秒前
沉默凌寒完成签到,获得积分10
25秒前
cc完成签到,获得积分10
25秒前
26秒前
糖豆完成签到,获得积分10
26秒前
smottom完成签到,获得积分0
27秒前
贰鸟完成签到,获得积分0
27秒前
27秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038569
求助须知:如何正确求助?哪些是违规求助? 3576279
关于积分的说明 11374944
捐赠科研通 3305979
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815048